Company page
Actinium Pharmaceuticals, Inc. (delaware)
Actinium Pharmaceuticals, Inc. is a public company based in Delaware, trading under the ticker ATNM. The company operates in the American market and has a market capitalization of approximately $28.9 million. Actinium focuses on developing innovative therapies for cancer treatment.
- Ticker
- ATNM:AMEX
- Asset type
- Stock
- Market cap
- $44.0M
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- Exchange
- AMEX
- Currency
- USD